RNA Technology Driving the New Wave of Therapeutics, 2018 Market Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 26, 2018--The “RNA Technology Driving the New Wave of Therapeutics” report has been added to ResearchAndMarkets.com’s offering.
This Drug Discovery TOE depicts trends across RNA technology driving a new wave of therapeutics. Different, stable, non-Immunogenic mRNA therapies, targeted RNAi technologies and therapeutics, CAR T-cell therapy, antisense therapeutics, RNA-based delivery platforms, and DNA-directed RNAi approaches are discussed in the TOE. Clinical trials of HIV vaccines is also depicted.
Key Topics Covered:
Innovations in Drug Discovery and DevelopmentTargeted RNAi Technology for Enhanced Disease Management Developing Stable and Non-immunogenic mRNA Therapies Enabling Potent Antisense Therapeutics Fueling Novel RNA Therapy and Delivery Platforms Enabling Targeted Delivery of RNAi Therapeutics Positive Interim Data from Clinical Study of RNA-based Treatment Long-term Expression Using DNA-directed RNAi Approach Improving Immunotherapy by Enhancing CAR T-cell Therapy RNAi Drug Enters Clinical Study for Scar Reduction and Bile Duct Cancer
Drug Discovery Technology Focus and TrendsClinical Trial Analysis Industry Interactions
For more information about this report visit https://www.researchandmarkets.com/research/xwhm74/rna_technology?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180926005896/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/26/2018 02:26 PM/DISC: 09/26/2018 02:26 PM